Form 4: uniQure Director Sells Shares Under 10b5-1 Plan

uniQure Director Robert Gut executed a pre-planned sale of ordinary shares, following the exercise of stock options, as disclosed in a recent Form 4 filing.

Summary

• Director Robert Gut of uniQure N.V. reported transactions involving ordinary shares on November 6, 2025.
• The transactions were executed pursuant to a Rule 10b5-1 sales plan adopted by Gut on July 8, 2025.
• Gut exercised 15,840 stock options at an exercise price of $4.57 per share.
• Subsequently, Gut sold 15,840 ordinary shares at a weighted average price of $27.22 per share.
• An additional 15,594 ordinary shares were sold at a price of $27.30 per share.
• The stock option vested in full on June 19, 2025.
• The filing also included adjustments to reflect a previously omitted sale of 1,120 shares on June 23, 2020, and a correction to a typographical error for 20 shares sold on June 13, 2024.

Sentiment

Score: 4

Explanation: The sale of a substantial number of shares by a director, even under a pre-arranged plan, typically leads to a slightly negative market sentiment as it reduces insider ownership and can be perceived as a lack of conviction in future stock price appreciation.

Positives

• The exercise of stock options at $4.57 indicates a significant in-the-money position for the director.
• The transactions were executed under a pre-arranged Rule 10b5-1 plan, demonstrating adherence to insider trading regulations.

Negatives

• Director Robert Gut sold a total of 31,434 ordinary shares (15,840 + 15,594) in the open market.
• The sales occurred at prices significantly higher than the option exercise price, potentially indicating a belief that the stock price is favorable for selling.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Director Robert Gut's exercise of stock options and subsequent sale of ordinary shares.

Stakeholder Impact

• Shareholders: Potential negative sentiment due to insider selling, which may be interpreted as a signal regarding the company's future prospects or valuation.

Key Dates

Recommendation

While the transactions were pre-planned under a 10b5-1 plan, the sale of a significant number of shares by a director, even after exercising options, typically does not provide a strong positive signal for new investment. It suggests the director is monetizing holdings rather than increasing exposure, leading to a neutral to slightly cautious stance.

Keywords

uniQure, QURE, Form 4, insider trading, stock options, share sale, director, 10b5-1 plan